GlassScriptPhysician profile
Floyd Joseph Johnson
NPI 1033340799
$1,214.67
in general payments reported to CMS, 2019-2025
19 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $600 · 2022: $308 · 2023: $26.25 · 2024: $91.12 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $160.52 | 2021 | |
| Allergan, INC. | $141.66 | 2021-2022 | |
| Boston Scientific Corporation | $131.57 | 2021-2025 | General - Pain Management |
| Abbvie INC. | $120.41 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $114.54 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $101.35 | 2022 | |
| Amgen INC. | $71.84 | 2021-2024 | Krystexxa |
| Almatica Pharma LLC | $50.57 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $46.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $39.91 | 2022-2025 | Farxiga |
| Lilly USA, LLC | $34.16 | 2021 | |
| Calliditas Therapeutics US INC. | $33.05 | 2025 | Tarpeyo |
| Vifor Pharma, INC. | $32.96 | 2025 | Veltassa |
| Bayer Healthcare Pharmaceuticals INC. | $32.62 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.25 | 2023 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $24.46 | 2024 | Xphozah 30 Mg |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.53 | 2022 | |
| Pfizer INC. | $14.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.